A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal disease
- 1 December 2004
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 66 (6), 2446-2453
- https://doi.org/10.1111/j.1523-1755.2004.66022.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Anaphylactic and Anaphylactoid Reactions Associated With Lepirudin in Patients With Heparin-Induced ThrombocytopeniaCirculation, 2003
- Anti-Platelet Factor 4/Heparin AntibodiesCirculation, 2003
- HEPARIN‐INDUCED THROMBOCYTOPENIA IN DIALYSIS: Alternative Methods of Anticoagulation for Dialysis‐dependent Patients with Heparin‐induced ThrombocytopeniaSeminars in Dialysis, 2003
- How I treat heparin-induced thrombocytopenia and thrombosisBlood, 2003
- Hirudin In Renal InsufficiencySeminars in Thrombosis and Hemostasis, 2002
- Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin‐induced thrombocytopeniaCatheterization and Cardiovascular Interventions, 2002
- Effect of the Thrombin Inhibitor Argatroban in Acute Cerebral ThrombosisSeminars in Thrombosis and Hemostasis, 1997
- Effect of thrombin inhibition on patients with peripheral arterial obstructive disease: A multicenter clinical trial of argatrobanJournal of Thrombosis and Thrombolysis, 1995
- Anticoagulant Therapy in a Congenital Antithrombin III (ATIII)-Deficient Patient with Chronic Renal Failure Undergoing Regular HemodialysisBiomaterials, Artificial Cells and Immobilization Biotechnology, 1991
- Effect of synthetic thrombin inhibitor (MD805) as an alternative drug on heparin induced thrombocytopenia during hemodialysisThrombosis Research, 1988